110 related articles for article (PubMed ID: 9391306)
1. [2-5 AS activity in serum and peripheral blood mononuclear cells for chronic active hepatitis C and the relationship to clinical outcome of interferon therapy].
Toda K; Kumagai N; Iwabuchi N; Suzuki T; Saito H; Morizane T; Hibi T; Ishii H; Tsuchimoto K
Nihon Rinsho Meneki Gakkai Kaishi; 1997 Oct; 20(5):428-36. PubMed ID: 9391306
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing the response to interferon therapy in chronic hepatitis C. Studies on viral genotype and induction of 2',5'-oligoadenylate synthetase in the liver and peripheral blood cells.
Grandér D; Hultcrantz R; Weiland O; Xu B; Sangfelt O; Björklund AC; Befrits R; Björkholm M; Gruber A; Kinnman N; Reichard O; Widell A; Einhorn S
Scand J Gastroenterol; 1996 Jun; 31(6):604-11. PubMed ID: 8789901
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms of the effect of interferon (IFN) therapy in patients with type B and C chronic hepatitis].
Karino Y
Hokkaido Igaku Zasshi; 1993 May; 68(3):297-309. PubMed ID: 7686526
[TBL] [Abstract][Full Text] [Related]
4. Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B.
Shindo M; Okuno T; Matsumoto M; Takeda M; Takino T; Sokawa J; Iwata A; Sokawa Y
Hepatology; 1988; 8(2):366-70. PubMed ID: 2451634
[TBL] [Abstract][Full Text] [Related]
5. Effect of interferon treatment on serum 2',5'-oligoadenylate synthetase levels in hepatitis C-infected patients.
Murashima S; Kumashiro R; Ide T; Miyajima I; Hino T; Koga Y; Ishii K; Ueno T; Sakisaka S; Sata M
J Med Virol; 2000 Oct; 62(2):185-90. PubMed ID: 11002247
[TBL] [Abstract][Full Text] [Related]
6. Activity of the interferon-induced 2',5'-oligoadenylate synthetase in patients with chronic hepatitis C.
Pawlotsky JM; Hovanessian A; Roudot-Thoraval F; Lebon P; Robert N; Bouvier M; Babany G; Duval J; Dhumeaux D
J Interferon Cytokine Res; 1995 Oct; 15(10):857-62. PubMed ID: 8564707
[TBL] [Abstract][Full Text] [Related]
7. Decreased interferon binding capacity of peripheral blood mononuclear cells during interferon treatment of chronic hepatitis B with special reference to (2'-5') oligoadenylate synthetase activity.
Shindo M; Iwata A; Okuno T; Matsumoto M; Takeda M; Arai K; Sokawa Y
Gastroenterol Jpn; 1989 Dec; 24(6):670-5. PubMed ID: 2481600
[TBL] [Abstract][Full Text] [Related]
8. 2'-,5'-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis C.
Kim KI; Kim SR; Sasase N; Taniguchi M; Harada S; Kinoshita K; Kim SH; Akimoto Y; Shikata M; Kimura N; Izawa S; Ohtani A; Nakao K; Motojima M; Kinoshita M; Hirai M; Ohzu M; Hirooka T; Nabeshima S; Ishii F; Tanaka K; Hotta H
J Clin Pharm Ther; 2006 Oct; 31(5):441-6. PubMed ID: 16958821
[TBL] [Abstract][Full Text] [Related]
9. Effect of in vitro interferon-beta administration on hepatitis C virus in peripheral blood mononuclear cells as a predictive marker of clinical response to interferon treatment for chronic hepatitis C.
Mochizuki K; Kagawa T; Takashimizu S; Kawazoe K; Kojima S; Nagata N; Nakano A; Nishizaki Y; Shiraishi K; Itakura M; Watanabe N; Mine T; Matsuzaki S
World J Gastroenterol; 2004 Mar; 10(5):733-6. PubMed ID: 14991949
[TBL] [Abstract][Full Text] [Related]
10. Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha.
Pawlotsky JM; Hovanessian AG; Roudot-Thoraval F; Robert N; Bouvier M; Babany G; Duval J; Dhumeaux D
Antimicrob Agents Chemother; 1996 Feb; 40(2):320-4. PubMed ID: 8834873
[TBL] [Abstract][Full Text] [Related]
11. [2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells obtained from patients with chronic hepatitis B during interferon therapy].
Sugawara T
Hokkaido Igaku Zasshi; 1990 Sep; 65(5):439-54. PubMed ID: 2227795
[TBL] [Abstract][Full Text] [Related]
12. Significance of 2',5'-oligoadenylate synthetase activity and HCV genotype in IFN therapy for type C chronic hepatitis.
Karino Y; Hige S; Matsushima T; Miyazaki T; Toyota J
Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1354-9. PubMed ID: 7705748
[TBL] [Abstract][Full Text] [Related]
13. HCV NS5A 2209-2248 amino acid substitutions affect serum 2,5AS activities.
Murashima S; Kumashiro R; Ide T; Sata M
J Hepatol; 1999 Aug; 31(2):382. PubMed ID: 10453957
[No Abstract] [Full Text] [Related]
14. Elevated levels of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during acute exacerbation of chronic hepatitis B.
Shindo M; Okuno T; Arai K; Matsumoto M; Takeda M; Takino T; Sokawa Y
Hepatology; 1989 May; 9(5):715-9. PubMed ID: 2468593
[TBL] [Abstract][Full Text] [Related]
15. In vitro effect of amantadine and interferon alpha-2a on hepatitis C virus markers in cultured peripheral blood mononuclear cells from hepatitis C virus-infected patients.
Martín J; Navas S; Fernández M; Rico M; Pardo M; Quiroga JA; Zahm F; Carreño V
Antiviral Res; 1999 May; 42(1):59-70. PubMed ID: 10333143
[TBL] [Abstract][Full Text] [Related]
16. Effect of obesity on pharmacokinetics and biologic effect of interferon-alpha in hepatitis C.
Lam NP; Pitrak D; Speralakis R; Lau AH; Wiley TE; Layden TJ
Dig Dis Sci; 1997 Jan; 42(1):178-85. PubMed ID: 9009135
[TBL] [Abstract][Full Text] [Related]
17. HCV-RNA assay in peripheral blood mononuclear cells in relation to IFN therapy.
Okuda M
Gastroenterol Jpn; 1993 Aug; 28(4):535-40. PubMed ID: 8397131
[TBL] [Abstract][Full Text] [Related]
18. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C.
Xu DZ; Xie Y; Li ZQ
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):550-3. PubMed ID: 16286260
[TBL] [Abstract][Full Text] [Related]
19. [Changes of serum 2',5'-oligoadenylate synthetase activity and neopterin during interferon treatment for chronic hepatitis C].
Daito K; Suou T; Kawasaki H
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):981-5. PubMed ID: 7563914
[No Abstract] [Full Text] [Related]
20. Effect of interferon alfa and ribavirin treatment on hepatitis C virus RNA in serum and peripheral blood mononuclear cells in children with chronic hepatitis C.
Majda-Stanisławska E; Bednarek M; Jóźwiak B; Sidorkiewicz M; Piekarska A; Kuydowicz J
Acta Gastroenterol Belg; 2006; 69(2):187-90. PubMed ID: 16929613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
